TMBIM4 and Alzheimer disease: We recently found that pridopidine treatment stabilizes mushroom spines in these models of AD, but not in the absence of endogenous S1R, indicating that observed beneficial effects are mediated through ligand-dependent activation of S1R (Ryskamp et al., 2019).